Pharmafile Logo

OTC Awards

- PMLiVE

CureVac announces start of phase 1/2 seasonal influenza vaccine trial

The multivalent mRNA candidates have been developed in collaboration with GSK

- PMLiVE

Role of pharmacists widened under England’s new GP recovery plan

The plan is expected to free up around 15 million GP appointments over the next two years

- PMLiVE

WHO declares end to COVID-19 global public health emergency

The agency’s emergency committee said it is time to transition to long-term management of the pandemic

Origins’ Solutions Offering Explained

Providing patient solutions that are wanted, needed, accessible, and fit for purpose can help companies to increase the value and success of their products and gain respect and recognition for...

Origins – The Patient Focused Specialists

Leveraging virtual tools to get the most out of hybrid congresses

Tips on how to optimize congress information-gathering...

Impetus Digital

- PMLiVE

Eli Lilly’s Alzheimer’s drug shown to significantly slow disease progression in phase 3 trial

Donanemab slowed the progression of early Alzheimer’s disease by 35% compared to placebo

- PMLiVE

AI model shows promise in detecting lung cancer earlier

Lung cancer accounts for more than 20% of cancer deaths in the UK

- PMLiVE

Improving outcomes for prostate cancer patients

Prostate cancer is the most common cancer in men across the United Kingdom, with approximately one in eight men being diagnosed with prostate cancer at some point in their life

Closing the Gaps in Telehealth

Anthony Capone, President of DocGo, shares how his company uses last-mile mobile health services and integrated medical transportation solutions to make healthcare more accessible for everyone, including underserved populations.To find...

Impetus Digital

- PMLiVE

Medscape Present Outcomes of Neurology Education at AAN 2023

Medscape had education outcomes on the brain for this year’s AAN conference in Boston.During the conference, Medscape presented 5 scientific posters describing the impact of continuing medical education in migraine,...

Medscape Education

ChatGPT AI copywriter: Looming threat or opportunity to evolve?

Even as someone who makes a living working in healthcare communications, I can still spend many hours copywriting without much progress – it is the nature of the beast [come...

Page & Page Health

- PMLiVE

Janssen signs $245m deal with Cellular Biomedicine for pair of CAR T-cell therapies

The candidates have shown the potential to treat forms of non-Hodgkin’s lymphoma

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links